During the past decade, Lisichansk TB Dispensary conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lisichansk TB Dispensary" #1 collaborator was "Immunitor USA Inc." with 2 trials as a collaborator and "National Medical University, Ukraine" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Lisichansk TB Dispensary" are "Tuberculosis" (2 trials). Many other conditions were trialed in "Lisichansk TB Dispensary" in a lesser frequency.

Most popular intervention types in "Lisichansk TB Dispensary" are "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "V-5 immunitor" (1 trials), "V7" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lisichansk TB Dispensary" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Lisichansk TB Dispensary". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Lisichansk TB Dispensary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lisichansk TB Dispensary, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".